May A Beydoun1, Jordan Weiss2, Hardeep K Obhi3, Hind A Beydoun4, Gregory A Dore3, Hailun Liang5, Michele K Evans3, Alan B Zonderman3. 1. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, Baltimore, MD, United States. Electronic address: baydounm@mail.nih.gov. 2. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, Baltimore, MD, United States; Population Studies Center and the Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. 3. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, Baltimore, MD, United States. 4. Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, United States. 5. Department of Health Policy and Management, Johns Hopkins School of Public Health, Baltimore, MD, United States.
Abstract
BACKGROUND: Chronic systemic inflammation has been positively associated with structural and functional brain changes representing early markers of Alzheimer's Disease (AD) and cognitive decline. The current study examined associations between systemic inflammation and cognitive performance among African-Americans and Whites urban adults. METHODS: Participants were selected from the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study (2004-2013, baseline age: 30-64 y, mean ± SD follow-up time of 4.64 ± 0.93 y, N = 189-222, k = 1.5-1.7 observations/participant). Cytokines known to be positively linked to AD incidence among others were tested against cross-sectional and longitudinal cognitive function, stratifying by age group (≤50 y vs. >50 y), sex and race. A series of mixed-effects regression models were conducted, adjusting for key confounders. RESULTS: Among key findings, IL1β was positively associated with a faster rate of decline on a test of executive functioning, among older adults (age >50 y, γ11 = +2.49 ± 0.89, p = 0.005), while in the total population, IL-6 was linked to a faster decline on a test of verbal memory (γ11 = -0.011 ± 0.004, p = 0.009). Among younger participants, IL-18 was linked to a poorer performance on a test of attention at baseline (age ≤50 y, γ01 = -0.007 ± 0.0025, p = 0.004) though a slower rate of decline with higher IL-18 was detected for a test of psychomotor speed in older adults (age >50 y, γ11 = +0.0010 ± 0.0004, p = 0.008). Finally, among Whites, unlike among African-Americans, IL-6 was associated with a better baseline performance on two tests of verbal and working memory. CONCLUSIONS: Cytokines were shown to be associated with age-related cognitive decline among middle-aged and older urban adults in an age group and race-specific manner. Further longitudinal studies are needed to replicate our findings and mediation through relevant biological and psychosocial factors need to be studied as well. Published by Elsevier Inc.
BACKGROUND:Chronic systemic inflammation has been positively associated with structural and functional brain changes representing early markers of Alzheimer's Disease (AD) and cognitive decline. The current study examined associations between systemic inflammation and cognitive performance among African-Americans and Whites urban adults. METHODS:Participants were selected from the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study (2004-2013, baseline age: 30-64 y, mean ± SD follow-up time of 4.64 ± 0.93 y, N = 189-222, k = 1.5-1.7 observations/participant). Cytokines known to be positively linked to AD incidence among others were tested against cross-sectional and longitudinal cognitive function, stratifying by age group (≤50 y vs. >50 y), sex and race. A series of mixed-effects regression models were conducted, adjusting for key confounders. RESULTS: Among key findings, IL1β was positively associated with a faster rate of decline on a test of executive functioning, among older adults (age >50 y, γ11 = +2.49 ± 0.89, p = 0.005), while in the total population, IL-6 was linked to a faster decline on a test of verbal memory (γ11 = -0.011 ± 0.004, p = 0.009). Among younger participants, IL-18 was linked to a poorer performance on a test of attention at baseline (age ≤50 y, γ01 = -0.007 ± 0.0025, p = 0.004) though a slower rate of decline with higher IL-18 was detected for a test of psychomotor speed in older adults (age >50 y, γ11 = +0.0010 ± 0.0004, p = 0.008). Finally, among Whites, unlike among African-Americans, IL-6 was associated with a better baseline performance on two tests of verbal and working memory. CONCLUSIONS: Cytokines were shown to be associated with age-related cognitive decline among middle-aged and older urban adults in an age group and race-specific manner. Further longitudinal studies are needed to replicate our findings and mediation through relevant biological and psychosocial factors need to be studied as well. Published by Elsevier Inc.
Authors: Matthew A Allison; Michael H Criqui; Robyn L McClelland; JoAnn M Scott; Mary M McDermott; Kiang Liu; Aaron R Folsom; Alain G Bertoni; A Richey Sharrett; Shunichi Homma; Sujata Kori Journal: J Am Coll Cardiol Date: 2006-08-28 Impact factor: 24.094
Authors: Fabian Corlier; George Hafzalla; Joshua Faskowitz; Lewis H Kuller; James T Becker; Oscar L Lopez; Paul M Thompson; Meredith N Braskie Journal: Neuroimage Date: 2018-01-28 Impact factor: 6.556
Authors: Yuan Lu; Shengfan Zhou; Rachel P Dreyer; Erica S Spatz; Mary Geda; Nancy P Lorenze; Gail D'Onofrio; Judith H Lichtman; John A Spertus; Paul M Ridker; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2017-02-22
Authors: S P Mooijaart; N Sattar; S Trompet; J Lucke; D J Stott; I Ford; J W Jukema; R G J Westendorp; A J M de Craen Journal: J Intern Med Date: 2013-03-11 Impact factor: 8.989
Authors: May A Beydoun; Gregory A Dore; Jose-Atilio Canas; Hailun Liang; Hind A Beydoun; Michele K Evans; Alan B Zonderman Journal: Front Aging Neurosci Date: 2018-10-09 Impact factor: 5.750
Authors: May A Beydoun; Danielle Shaked; Salman M Tajuddin; Jordan Weiss; Michele K Evans; Alan B Zonderman Journal: Neurology Date: 2019-12-26 Impact factor: 9.910
Authors: Lauren E Oberlin; Kirk I Erickson; Rachel Mackey; William E Klunk; Howard Aizenstein; Brian J Lopresti; Lewis H Kuller; Oscar L Lopez; Beth E Snitz Journal: Brain Behav Immun Date: 2021-03-15 Impact factor: 19.227
Authors: Jessica Z K Caldwell; Jefferson W Kinney; Aaron Ritter; Arnold Salazar; Christina G Wong; Dietmar Cordes; George M Slavich Journal: Brain Behav Immun Date: 2020-12-08 Impact factor: 19.227